Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00139906
- Locations
- ๐บ๐ธ
Site 1, National City, California, United States
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00134251
- Locations
- ๐ท๐ธ
Site 34, Belgrade, Serbia
๐ง๐ฌSite 14, Sofia, Bulgaria
๐ท๐ธSite 33, Nis, Serbia
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00126074
- Locations
- ๐บ๐ธ
Site 26, Honolulu, Hawaii, United States
๐บ๐ธSite 27, Tullahoma, Tennessee, United States
๐ฉ๐ชSite 8, Mannheim, Germany
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00126061
- Locations
- ๐ต๐ฑ
Site 12, Medyczna, Poland
๐ท๐บSite 17, Moscow, Russian Federation
๐ต๐ฑSite 11, Lodz, Poland
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00126022
- Locations
- ๐ต๐ฑ
Site 33, Szczecin, Poland
๐ท๐ดSite 37, Tg. Mures, Romania
๐ฎ๐ฑSite 22, Jerusalem, Israel
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00123201
- Locations
- ๐บ๐ธ
Site 1, Chicago, Illinois, United States
๐บ๐ธSite 2, Boston, Massachusetts, United States
๐บ๐ธSite 7, St. Petersburg, Florida, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath